Sponsor intelligence · OTHER
Clinical trials sponsored by
Peking University Third Hospital.
Real, source-linked trial activity for Peking University Third Hospital: 10 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 20, 2026. Source-linked, daily-refreshed.
NA 7N/A 2PHASE2 1
Newest Peking University Third Hospital trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 4d ago | Sustentaculum Tali Screw Fixation Mode and Postoperative Foot-Ankle Fu | N/A | NOT_YET_RECRUITING | ↗ |
| 4d ago | Effects of Different Stiffness Settings During Robotic Isokinetic Trai | NA | NOT_YET_RECRUITING | ↗ |
| 20d ago | BCT301 in Treating Refractory/Recurrent IgG4-related Disease | NA | NOT_YET_RECRUITING | ↗ |
| 27d ago | A Randomized Controlled Trial: Fuzheng Yangxin Formula for ERAS After | NA | NOT_YET_RECRUITING | ↗ |
| 30d ago | Multistage Additive Manufacturing for Complex Limb Bone Deformity Reco | N/A | ENROLLING_BY_INVITATION | ↗ |
| 39d ago | 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors | NA | RECRUITING | ↗ |
| 41d ago | The Effect of Ligament of Marshall Excision During Minimally Invasive | NA | NOT_YET_RECRUITING | ↗ |
| 47d ago | Unplanned Return to the Operating Room in Orthopaedics: Closed-Loop Qu | NA | NOT_YET_RECRUITING | ↗ |
| 48d ago | Comparison of Postoperative Functional Outcomes Between Subvastus and | NA | NOT_YET_RECRUITING | ↗ |
| 48d ago | Mirvetuximab Soravtansine Combined With Suvemcitug in Platinum-Resista | Ph 2 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Peking University Third Hospital (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.